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Abstract
To understand the underlying mechanisms of significant differences in dissociation rate constant among different inhibitors
for HIV-1 protease, we performed steered molecular dynamics (SMD) simulations to analyze the entire dissociation
processes of inhibitors from the binding pocket of protease at atomistic details. We found that the strength of hydrogen
bond network between inhibitor and the protease takes crucial roles in the dissociation process. We showed that the
hydrogen bond network in the cyclic urea inhibitors AHA001/XK263 is less stable than that of the approved inhibitor
ABT538 because of their large differences in the structures of the networks. In the cyclic urea inhibitor bound complex, the
hydrogen bonds often distribute at the flap tips and the active site. In contrast, there are additional accessorial hydrogen
bonds formed at the lateral sides of the flaps and the active site in the ABT538 bound complex, which take crucial roles in
stabilizing the hydrogen bond network. In addition, the water molecule W301 also plays important roles in stabilizing the
hydrogen bond network through its flexible movement by acting as a collision buffer and helping the rebinding of
hydrogen bonds at the flap tips. Because of its high stability, the hydrogen bond network of ABT538 complex can work
together with the hydrophobic clusters to resist the dissociation, resulting in much lower dissociation rate constant than
those of cyclic urea inhibitor complexes. This study may provide useful guidelines for design of novel potent inhibitors with
optimized interactions.
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Introduction
Human immunodeficiency virus type 1 (HIV-1) protease is a
symmetric homo-dimeric aspartyl protease, whichcleaves the gag and
pol viral polyproteins at its active site to process viral maturation [1].
Due to its indispensability for the infection of the virus, the HIV-1
protease (HIV-1 PR) is one of the primary targets of anti-AIDS
therapy [2]. However, new potent inhibitors are still often needed
because of the selection of inhibitor-resistant variants of the protease
(PR), which leads to limited long term use of current inhibitors. To
improve the efficacy of inhibitors, many efforts had been paid for
studying the kinetic processes of association and dissociation of the
interaction between inhibitors and the HIV-1 PR. It was found that
current inhibitors, including the approved and the non-approved,
exhibit distinct kinetic processes, of whichthe underlying mechanisms
are of primary importance for structure-based drug design. For
instance, experimental results indicated that there are a wide range of
association rate and dissociation rate constants in different inhibitors,
e.g., kon&10
9,10
10 M
21s
21 and koff&,100 s
21 for cyclic urea
inhibitors, while kon&10
5,10
6 M
21s
21 and koff&10
23,10
24 s
21
for the approved inhibitors [3]. To understand these significant
differences in the association rate and dissociation rate constants has
been a primary impetus behind intensive studies.
The effectiveness of inhibitors is often denoted by the compound
parameter, KD~koff

kon [3], which suggests that the efficacy
optimization of new potent inhibitors should be guided by aiming
for high association and low dissociation rates simultaneously rather
than high association rate alone [3]. Molecular dynamics (MD)
simulation, as a powerful tool for studying the kinetic process of
inhibitors, can be used for identifying crucial factors that influence
the association and dissociation processes of inhibitors during the
structure-based drug design. To understand the binding behaviors
of inhibitors with the PR, both full-atom and coarse grained (CG)
MD methods wereadopted to simulate the dynamics of freePR and
PR-inhibitor complex [4,5,6,7,8,9,10,11]. Chang et al. [12] studied
the binding pathway of a cyclic urea inhibitor XK263 and a
substrate using CG MD simulations. Pietrucci et al. [13] studied the
binding mechanism of a substrate using MD simulations with a
so-called bias-exchange metadynamics technique. Li et al. [8] and
Cheng et al. [14] further simulated the binding process of various
inhibitors of different binding energy, molecular size and rigidity
with CG MD simulations. They showed that the binding process
was gated by the opening dynamics of the flaps of the PR, and
this gated binding processes can be significantly affected by
molecular properties of inhibitors, such as inhibitors’ size,
topology and stiffness. These studies to some extent explained
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e19268the mechanisms for the wide variety of association rate constants
in different inhibitors.
Compared with the association process, the dissociation process
of inhibitors is much less understood. The experiments by
Maschera et al. [15] indicated that the mutations of the protease
often decreased the effectiveness of inhibitors by significantly
increasing the dissociation rate constants, but tinily influencing the
association rate constants. This result indicates that the dissocia-
tion rate is more sensitive to the mutations, in which the
underlying mechanisms are important for potent inhibitor design.
In addition, Markgren et al. [3] showed that the affinities of the
cyclic urea inhibitors were often limited by its ultra fast
dissociation rates. To study the dissociation processes, Trylska et
al. [16] studied the dynamics of product release process with CG
MD simulations. Sadiq et al. [17] simulated the early stages of
release process of inhibitors by all-atom MD simulations and
found that there is a lateral escaping tendency of inhibitors assisted
by mutations of the PR. Li et al. [10] studied the role of the sub-
nanosecond local dynamics of flap tips in the stability of the bound
complexes and showed that the local dynamics are affected by
broken and formation of hydrogen bonds between flap tips and
inhibitors. They found that the water molecule W301 within the
binding pocket of bound complex plays crucial roles in the binding
stability of inhibitors. To the best of our knowledge, there is no
report on studies of entire dissociation processes of inhibitors from
the HIV-1 PR with full atom simulations. Compared to the coarse
grained simulation, the full-atom simulation allows us to track the
atomistic details in the dynamics of system. The information in
atomistic details of the dissociation processes of inhibitors from
HIV-1 PR is of importance for optimizing the interactions during
inhibitor design.
In this paper, we will apply the steered molecular dynamics
(SMD) simulations to study the dissociation behaviors of inhibitors
under external force considering that the time scale of dissociation
processes is beyond the limit of classical MD simulations. For
example, the timescale of the natural dissociation process of cyclic
urea inhibitors is estimated to be ,10 ms considering their
dissociation rate constants being ,100 s
21 [3], while the timescale
the classical full-atom MD simulations can achieve is typically
nano- to micro-seconds. By applying a force to the system, the
dissociation processes can be largely accelerated in the SMD
simulation. This kind of single-molecule pulling simulations or
experiments has been widely used to investigate the ligand-
receptor interactions [18,19], the protein-protein interactions [20],
as well as the unfolding processes of proteins [21,22]. Particularly,
they can be used to calculate the profile of the free energy
landscape of the molecular interaction [23,24,25,26,27,28,29,30].
Here we will apply the SMD simulation to study the critical
interactions between inhibitors and the PR at atomistic details.
The umbrella sampling method [31] will be applied to calculate
the profiles of the energy landscapes of the systems. The aim of this
work is to find the underlying mechanisms at atomistic details that
influence the dissociation rate of different inhibitors, through
which to obtain useful guidelines for design of novel potent
inhibitors.
Methods
MD simulations
The structures for the inhibitor bound complexes were retrieved
from Protein Data Bank with PDB codes: 1AJX [32] for AHA001
bound complex, 1HVR [33] for XK263 bound complex and
1HXW [34] for ABT538 bound complex. The catalytic Asp side
chains of the bound complex were protonated according to the
experiments and theoretical calculations, i.e. both side chains of
Asp25/Asp259 were protonated for AHA001 and XK263 bound
complex [35], and only one of the Asp25/Asp259 was protonated
for ABT538 bound complex [36].
The MD simulations were performed using Gromacs package
[37] with the AMBER force field of ffamber99 [38], in which the
all-atom force field parameters of inhibitors were obtained by the
ANTECHAMBER module and GAFF [39] with AM1-BCC [40]
charges in AMBER package [41].
Each system was solvated in a 90680680 A ˚ 3 water box, with
about 15,000 water molecules. Appropriate chlorine ions were
added to neutralize the system. Particle Mesh Ewald (PME)
method [42] was used to calculate the long-range electrostatic
interactions. The systems were minimized firstly using steepest
descent algorithm by 10,000 steps. Then, the system was gradually
heated from 200K to 300K in 200 ps, while positional restraints
were used for the heavy atoms of the protease and the inhibitor.
The restraint force constants were gradually decreased from
1660 pN/nm to 0 pN/nm in a few stages. All production
simulations were conducted at 300K and 1 bar with the Berendsen
algorithm. The LINCS algorithm [43] was applied to constrain
the covalent bonds with H-atoms. The time step of the simulations
is 2.0 fs. The cut-off of the non-bonded interactions was set to be
10 A ˚. The non-bonded pairs were updated in every 10 steps.
Steered MD simulations
Structures from the result of each 40 ns MD simulations were used
as starting configurations for steered MD (SMD) simulations. We
used a constantpulling speedto applyforce tothesystem. The steered
‘‘dummy’’ atom was attached via a spring to the center of mass
(COM) of the inhibitors and moves at a constant velocity. In the
SMD simulation, the applied force is given by f~kspring vt{x0 ðÞ ,
where kspring is the spring constant, v isthe pulling velocityand t is the
simulation time. Thus the force rate can be obtained as f
.
~kspringv.
In order to study the binding strength of the bound complexes, we
carried out a series of computational experiments by using a large
range of force rate over six orders of magnitude, by systematically
varying the spring constant (kspring =6947.7 pN/nm, 3473.9 pN/
nm, 694.8 pN/nm, and 347.4 pN/nm)and the pulling velocity (from
200 nm/ns to 0.02 nm/ns), which is from 1.4610
6 pN/ns to
6.95 pN/ns. Each force rate was simulated more than twice to
calculate the average rupture forces and the deviations (see Table S1).
Because Sadiq et. al. [17] showed that the inhibitor tended to
laterally escape from the binding pocket, and Trylska et al. [16]
also showed that the peptide product would laterally slide out from
the binding pocket, we chose the pulling direction along the lateral
direction, depicted by the vector from the COM of residue Arg8 to
the COM of residue Arg89 (see Figure 1).
To prevent translational and rotational displacement of the PR
molecule, several Ca atoms of the PR were held by positional
restraints, including Ca atoms of N- and C-termini residues Pro1,
Phe99, Pro19 and Phe999, as well as Arg8, Leu23, Pro81 and
Asp309 at the back end of the PR.
Umbrella sampling
From the SMD simulation trajectories, snapshots were taken to
generate the starting configurations for the umbrella sampling
windows. For each inhibitor bound complex system, the simulation
trajectory with kspring =694.8 pN/nm and pulling velocity
0.02 nm/ns was chosen to apply the umbrella sampling analysis.
An asymmetrical distribution of sampling windows was used, such
that the window spacing was about 0.5 A ˚ when the COM
separation between the inhibitor and the PR active site (i.e. residues
Strength of Hydrogen Bond Network
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COM separation beyond 10 A ˚. Such spacing allowed for sampling
in detail at smaller COM distance, which resulted in about 40
windows.In each window, 5 ns of MD simulation was performed so
that a total simulation time of ,200 ns was utilized for umbrella
sampling in each system. Analysis of results was performed with the
weighted histogram analysis method (WHAM) [44].
Hydrogen Bond Criteria
To determine whether a hydrogen bond (H-bond) exists
between donor and acceptor, a geometrical criterion was adopted,
in which the formation of a hydrogen bond was defined by both
atom distance and bond orientation. For instance, the combina-
tion of donor D, hydrogen H, and acceptor A with a D-H??? A
configuration was regarded as a hydrogen bond when the distance
between donor D and acceptor A was shorter than 3.5 A ˚ as well as
the bond angle H-D??? A was smaller than 60.0u.
Results
H-bonds and hydrophobic interactions between the PR
and inhibitors
Figure 2 (a), (b) and (c) illustrated the H-bonds and hydrophobic
interactions between the inhibitors and the PR for three
complexes, AHA001-PR, XK263-PR and ABT538-PR, respec-
tively. Table 1 shows the root mean square deviation (RMSD)
values of protease Ca atoms of these complexes after 40 ns MD
simulations without applying external forces. The low RMSD
values indicated that the structures of the complexes were stable
and the configurations were close to the initial structures. The time
average number and the spatial distributions of H-bonds between
the protease and inhibitors were given in Table 1 (also see Figure 2
(a), (b) and (c)). For the cyclic urea inhibitors (i.e. AHA001 and
XK263), they formed one H-bond on average with the flap tips
(denoted by Ile50/Ile509:N–AHA001:O for AHA001, see Figure 2
(a); and Ile50/Ile509:N–XK263:O for XK263, see Figure 2 (b)),
while the inhibitor ABT538 formed about two H-bonds with flap
tips through a so-called W301 water molecule (denoted by Ile50/
Ile509:N–W301–ABT538, see Figure 2 (c)). In addition, two more
H-bonds were formed between ABT538 and residues Asp29 and
Gly48 at the lateral sides of the protease (denoted by Asp29:N–
ABT538:O42 and Gly48:O–ABT538:N16, respectively). We note
that all these three inhibitors formed multiple H-bonds with
residues Asp25 and Asp259 at the active site (denoted by Asp25/
Asp259–ABT538, Asp25/Asp259–AHA001 and Asp25/Asp259–
XK263, respectively, see Figure 2 (a) to (c)).
Besides H-bond interactions, inhibitors can also have hydro-
phobic interaction with the PR. There were several hydrophobic
clusters formed between the sidechains of the inhibitors and the
subsites of the protease, which can be represented by the distances
between the hydrophobic groups in the clusters (see Figure 2 (a) to
(c)). Through these interactions, the inhibitors bind at the active
site so that the protease can be restricted to the closed
configuration.
Figure 1. Carton draws of the HIV-1 protease in complex with inhibitor. Residue Arg8 and Arg89 were represented by VDW spheres. The
inhibitor was represented by green VDW spheres. The red arrow shows the directions of the external forces implemented in the SMD simulations. (a)
The front view of the bound complex; (b) The side view of the bound complex with an external force applied on the inhibitor.
doi:10.1371/journal.pone.0019268.g001
Figure 2. Illustration of molecular structures of inhibitors and their H-bonds and hydrophobic interactions with the protease. (a)
AHA001, (b) XK263 and (c) ABT538. Sidechains of the inhibitors are labeled as P1, P2, etc., and these sidechains can insert into the sub-sites of the
protease (labeled as S1, S2, etc.) to form hydrophobic clusters. The residues in protease are labeled in blue in (a), (b), and (c). The possible H-bonds
between the protease and inhibitors are labeled in green.
doi:10.1371/journal.pone.0019268.g002
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inhibitors from the PR binding pocket
AHA001 and XK263
Figure 3 (a) shows the snapshots of AHA001 escaping from the
active site under the external forces along the pulling pathway (see
Figure 1). When the external force was small at the initial stage, the
H-bonds at the flap tips firstly became unstable, see Figures 3 and 4
at 0,20 ns. The average H-bond number was about 4 (see Figure 4
(d)). With increasing of the pulling force to a critical value, the H-
bonds at the active site (Asp25/Asp259–AHA001) started to
rupture, and the average H-bond number decreased to 1, see
Table 1. RMSD values of the protease Ca atoms and number of H-bonds between the protease and the inhibitors after 40 ns MD
simulations.
Complex RMSD (A ˚) Total number of H-bonds Individual number of H-bonds
AHA001-PR 1.6660.09 4.5460.62 Asp25/Asp259–AHA001: (3.6160.54)
Ile50/Ile509:N–AHA001:O: (0.9360.33)
XK263-PR 1.3760.18 4.5660.87 Asp25/Asp259–XK263: (3.5660.65)
Ile50/Ile509:N–XK263:O: (1.0060.50)
ABT538-PR 1.1160.14 6.3860.72 Asp25/Asp259–ABT538: (2.7560.47)
Asp29:N–ABT538:O42 : (0.9760.17)
Gly48:O–ABT538:N16: (0.9160.29)
Ile50/Ile509:N–W301–ABT538: (1.7560.44)
doi:10.1371/journal.pone.0019268.t001
Figure 3. Dissociation process of AHA001 from the protease. (a) Snapshots of AHA001 escaping from the binding pocket of the protease
under the external pulling force. The numbers in the panel indicate the lengths of the H-bonds, and the simulation times are given at the bottom of
each snapshot. (b) The pulling force of the AHA001 bound complex during the SMD simulation. The red curve is the average values with a running
average time window of 500 ps. The blue arrows indicate the critical points of force dropping during the simulation.
doi:10.1371/journal.pone.0019268.g003
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three H-bonds of Asp25/Asp259–AHA001 ruptured simultaneous-
ly. With rupture of the H-bond network, the loading force dropped
abruptly, and the inhibitor was pulled to deviate from the binding
site, see Figure 3 (b) at about 22 ns and 30 ns. Afterwards, the
dissociation process of inhibitor was mainly resisted by the
hydrophobic interaction between the PR’s subsites and AHA001’s
sidechains via the hydrophobic clusters (i.e., clusters P1-S1, P19-S19,
P2-S2, P29-S29, see Figure 2 (a)). At last, the inhibitor AHA001 was
completely pulled out from the binding pocket, and the loading
force dropped to zero. Here the hydrophobic interactions were
measured by the center-of-mass distance between two hydrophobic
groups [17]. We monitored the evolutions of the distance during the
simulation (see Figure 4 (e) to (h)). When the distances was larger
than 10 A ˚ so that one or more layers of water molecules can enter
the space between them and separate them (the size of each
hydrophobic group is about 2,3A ˚), the hydrophobic interactions
were considered to be ruptured.
Thedissociationprocess ofinhibitorXK263wassimilar tothat of
AHA001. Firstly, the H-bonds at the flap tips became less stable
under the pulling force. Secondly, the H-bonds between XK263
and the active site (Asp25/Asp259-XK263) ruptured at a critical
value of the pulling force, as shown in Figure S1 (a) at 38.82 ns (also
see Figure S2 (a) to (d)), which then caused the failure of the whole
H-bond network. Thereafter, the inhibitor slipped away from the
active site, which caused a big drop in the loading force at ,40 ns
(seeFigureS1(b)). Thepulling force finally dropped to zero afterthe
rupture of the hydrophobic clusters between inhibitors and the
protease. There were also some differences between XK263 and
AHA001. The force value for the H-bonds’ failure at active site
(indicated by the first tip value of the force-time curve) of XK263 is
higher than that of AHA001, according to the comparison between
Figure 3 (b) and Figure S1 (b). In addition, the rupture of the H-
bonds at the active site in XK263 bound complex occurred later
than that in AHA001 bound complex. For AHA001 complex, most
of thehydrophobic clusters ruptured after the failureof the H-bonds
at active site (see Figure 4). However, for XK263 complex, most of
thehydrophobicclustersrupturedtogetherwith thefailure ofthe H-
bonds at active site (see Figure S2 (e) to (h)).
ABT538
In comparison with those in AHA001-PR and XK263-PR
complexes, the failure process of the H-bond network in ABT538-
PR complex was different. Figure 5 shows that the H-bond
network was stable till the pulling force reaching a much higher
value at t,52.50 ns, while the H-bond number was about 6 (see
Figure 6 (e)). Further increasing of the pulling force caused the
rupture of the H-bonds between the flap tips and the water
molecule W301, then W301 moved away from its original position
together with one flap tip. Interestingly, another water molecule
Figure 4. Analyses of the dynamics of H-bond interaction and hydrophobic interactions in AHA001 bound complex. (a) to (c): The H-
bond lengths between the protease and the inhibitor AHA001 during the SMD simulation. (d) Evolution of the number of H-bonds between the
protease and the inhibitor AHA001 during the simulation. (e) to (h): The distances between the subsites (S) of protease and the sidechains (P) of
inhibitor AHA001 during the simulation, which were used to monitor the state of the hydrophobic clusters. The blue arrows indicate the critical
points of bond length change during the simulation.
doi:10.1371/journal.pone.0019268.g004
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re-built the H-bond connections between flap tips and ABT538
together with the original W301 molecule. The two water
molecules W301 and W3019 formed a water chain between the
flap tips and the ABT538, as shown in Figure 5 (a) at 52.50 ns (see
also Figure 6 (d)). The water chain later ruptured under the pulling
force at t,60 ns, which cause only a slight drop of the pulling
force, and the H-bond number became 4 (see Figure 6 (e)). Then,
the H-bonds at lateral sides Asp29:N-ABT538:O42 and Gly48:O–
ABT538:N16 came into play in keeping the stability of the H-
bond network (see also Figure S3). With further increasing of the
pulling force, the H-bond Asp29:N-ABT538:O42 ruptured at
75.06 ns, as shown in Figure 5 (a). However, the H-bond
Gly48:O–ABT538:N16 was still stable. Therefore, the strength
of interactions between the PR and inhibitor ABT538 are still
strong enough to keep the stability of ABT538 in the binding
pocket. At this stage, the H-bond number became 3 (see Figure 6
(e)), and the hydrophobic clusters were also stable. Finally, with
further increase of the pulling force to a critical value, the H-bonds
Asp25/Asp259–ABT538 and Gly48:O–ABT538:N16, as well as
the hydrophobic clusters between the subsites of PR and the
sidechain of ABT538, ruptured together, and the inhibitor
ABT538 was pulled out from the binding pocket (see Figures 5
and 6). We noted that the distances between the hydrophobic
groups (e.g., S1-P1,S19-P19, S2-P2, S29-P29) increase abruptly to
be as high as 20 A ˚ at about 80 ns, together with the rupture of
most of H-bonds.
Rupture force
The dissociation processes were simulated by systematically
changing the pulling rate over six order of magnitude ranging
form 1.4610
6 pN/ns to 6.95 pN/ns, focusing on the effect of the
pulling rate on the rupture force. The rupture force was defined as
the highest peak value of the pulling force as shown in Figure 3
and 5. Figure 7 shows that the rupture forces of the three inhi-
bitor bound complexes change in exponential functions of the
pulling rates, which can be fitted with the function ffit kv ðÞ ~
Aexp ln kv ðÞ =B ½  [45], consistent with pervious studies that the
strength of molecular bonds increases as a weak power law of
loading rate [46]. We note that the force level was very high
because the pulling rates we used were much larger than those of
experiments. If we choose the force rate as ,100 pN/s which was
usually used in experiments [19,47], the rupture force can be
predicted by this fitting function as ,35.88 pN, 22.91 pN and
10.81 pN for ABT538, XK263 and AHA001, respectively. These
results are in good agreement with experimental results of
dissociation forces for antibody fragment-peptide complex (i.e.
,35 pN) [19] and unfolding forces for coiled-coil myosin structure
(i.e. ,30 pN) [47] measured by AFM in similar force rate ranges.
It can be seen that the curves of rupture force can quantitatively
distinguish the binding strength of these three inhibitors. For
example, the binding strength of ABT538 complex was stronger
than that of XK263 complexes, and that of XK263 was stronger
than that of AHA001 at different pulling rates. Our results were
consistent with recent studies by Colizzi et al. [48] which indicated
Figure 5. Dissociation process of ABT538 from the protease. (a) Snapshots of ABT538 escaping from the binding pocket of the protease
under the external pulling forces. The numbers in the panel indicate the lengths of the H-bonds, and the simulation times are given at the bottom of
each snapshot. (b) The pulling force of the ABT538 bound complex during the SMD simulation. The red curve is the average values with a running
average time window of 500 ps. The blue arrows indicate the critical points of force dropping during the simulation.
doi:10.1371/journal.pone.0019268.g005
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whereas the weaker inhibitors produced lower rupture forces.
The different binding strength or rupture forces among these
three inhibitors can be understood by considering the failure mode
of the H-bond network and the coordination between the H-bond
network and the hydrophobic clusters during the dissociation
process. As we can see, the cooperativity of H-bonds of ABT538
complex is more effective than those of AHA001/XK263
complexes. For example, in AHA001/XK263 complexes, one of
the two H-bonds at flap tips ruptured before the H-bonds at active
site, while the other one ruptured after those at active site.
However, most of H-bonds in ABT538 bound complex rupture
simultaneously. Our results were consistent with previous studies
[49,50,51] which showed that the cooperativity of H-bonds
facilitate to achieve strong binding strength in biomolecules. In
addition, we showed that the earlier the failure of the H-bond
network (especially the H-bonds at the active site), the lower the
rupture force. For example, the failure of the H-bonds in AHA001
was earlier than that of XK263, and that of XK263 was earlier
than that of ABT538. The underlying mechanism is that the
coordination of H-bonds with the hydrophobic interactions
between inhibitor and the PR is also crucial for the binding
strength of inhibitors. If the role of the H-bond network was
synchronized with that of the hydrophobic interactions, then the
binding strength could be optimized, as in the case of the
ABT538 complex. Because the H-bond is more sensitive to the
displacement of inhibitor relative to the binding site, in order to
improve the binding strength of inhibitors, the structure of the H-
bond network should be optimized. In the ABT538 bound
complex, we identified two mechanisms that can optimize the H-
bond network. One is having more accessorial H-bonds at lateral
sides of flap tips and active site for stabilizing the H-bond
network, as shown in the section for ABT538. The other one is
introducing water molecules W301/W3019. The water molecules
can be helpful for the stability of the connection between the flap
tips and the inhibitor with their flexible movement and rotation.
These two mechanisms let the H-bond networks and hydropho-
bic interactions ruptured simultaneously in inhibitor ABT538
bound complex with higher binding strength than those in the
AHA001 and XK263 bound complexes.
Energy landscape
The energy landscape of the dissociation process can be
determined by using the umbrella sampling simulations, and the
reaction coordinate corresponds to the pulling pathway (see
Figure 1). By using approximate 40 sampling windows along this
reaction coordinate, one-dimensional potential of mean force
(PMF) curves were obtained for each system. Table 2 shows the
parameters of the energy landscape of the three systems calculated
from umbrella sampling method compared with corresponding
Figure 6. Analyses of the dynamics of H-bond interaction and hydrophobic interactions in ABT538 bound complex. (a) to (d): The H-
bond lengths between the protease and the ABT538 during the pulling simulation. (e) Evolution of the number of H-bonds between the protease
and the ABT538 during the simulation. (f) to (j): The distances between the subsites (S) of protease and the sidechains (P) of the inhibitor ABT538
during the simulation, which were used to monitor the state of the hydrophobic clusters. The blue arrows indicate the critical points of bond length
change during the simulation.
doi:10.1371/journal.pone.0019268.g006
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several local minima in the energy landscape of AHA001 bound
complex which were separated by a few kBT energy barriers.
Therefore, the system states can transfer from one minimum to
another, which was believed to be one of the main factors causing
the instability of the system [48]. These local minima correspond
to the drops in the pulling force (see Figure 3 (a)), which were
caused by the instability of H-bond network. The position a in
Figure 8 (a) corresponds to the failure of the H-bonds at the active
site as well as the failure of the whole H-bond network (see also the
snapshot a in Figure 8). Thereafter, the stability of the bound
complex was maintained only by the hydrophobic clusters.
For XK263 bound complex, there were also local minima in the
energy landscape (see Figure 8 (b)). The position b in Figure 8 (b)
corresponds to the failure of the H-bond network of XK263 bound
complex (see also the snapshot b in Figure 8). The H-bond
networks failed approximately at the same position along the
reaction coordinate (about 3 A ˚) as that of the AHA001 bound
complex.
Different from the cyclic urea inhibitors, there was only one
energy well in the energy landscape of the ABT538 bound
complex before the rupture of the H-bond network along the
reaction coordinate. This suggested that the ABT538 bound
complex was more stable than that of cyclic urea inhibitors
(AHA001 and XK263) at the native position. Position c in Figure 8
(c) shows the position in the energy landscape when the H-bond
network ruptured (see also snapshot c in Figure 8).
Here we define the width of the energy well of the H-bond
network as the largest distances between the center of mass of
inhibitor and the active site of PR above which there was no H-
Figure 7. Rupture forces of the three inhibitor bound complexes calculated by the SMD simulations in term of pulling rates. The
rupture force was defined as the highest peak loading force during the dissociation process in SMD simulations. The solid lines are the exponential
fits according to pervious studies [45,46] to guide the view.
doi:10.1371/journal.pone.0019268.g007
Table 2. The energy landscape profiles calculated by the umbrella sampling method in comparison with the experiments.
a
Inhibitors Umbrella sampling Experiment values
DGcal
off
(kcal/mol) kcal
off (s
21) xb (A ˚)
DGH{bonds
(kcal/mol) xH{bonds
b (A ˚)
DGEx:
off
(kcal/mol) kEx:
off (s
21) Ki (nM) DG
d (kcal/mol) Refs.
AHA001 15.08 54.44 11.9 2.54 2.88 14.79 ,88.3
b 12.2 210.79 [3,63]
15.21 ,43.8
c
XK263 15.94 12.75 12.8 4.85 2.97 14.79 ,88.3
b 0.31 212.97 [3,64]
15.21 ,43.8
c
ABT538 20.20 9.59610
23 12.6 12.12 6.23 21.08 2.16610
23 0.59 212.59 [3]
aAs there is no experimental results for XK263 and AHA001 were determined, the kinetic behaviors of XK263 and AHA001 were represented by the data of their analog
like inhibitors DMP323 and AHA008 (see Figure S4).
bData from DMP323, Ki=0.27 nM.
cData from AHA008, Ki=0.23 nM.
dThe free energy DG is obtained by DG~{kBT ln Ki ðÞ .
doi:10.1371/journal.pone.0019268.t002
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well width of the H-bond network of ABT538 complex is 6.23 A ˚
that is over twice of those of the AHA001 and XK263 bound
complexes, 2.88 A ˚ and 2.97 A ˚, respectively (see Table 2 and
positions a, b and c in Figure 8 (a), (b) and (c)). In addition, the
energy barrier for the rupture of the H-bond network of the
ABT538 complex is much higher than those of the AHA001 and
XK263 complexes (see Table 2). Therefore, the H-bond network
was more stable in the ABT538 complex than those in the
AHA001/XK263 complexes.
Discussion
Using the SMD simulation method, we simulated the enforced
dissociation processes of three different inhibitors, AHA001,
XK263 and ABT538, from the binding pocket of the PR. We
showed that the dissociation processes of these three inhibitors
were different in several aspects including, e.g., the dissociation
time, rupture force, and the failure modes of H-bonds and
hydrophobic clusters as well as the coordination between these two
interactions. The results showed that the enforced dissociation
process of ABT538 was slower than those of the cyclic urea
inhibitors AHA001 and XK263, and the rupture force of ABA538
was larger than those of the cyclic urea inhibitors.
We showed that these differences could be understood by
studying the failure mechanisms of interaction between inhibitors
and the PR at atomistic details. We suggested that the stability of
H-bond network between inhibitors and the PR dominates the
binding strength and therefore the dissociation rate of the
inhibitors. Furthermore, the structure of the H-bond network,
i.e., the distribution of H-bonds, dominates the stability of the H-
bond network. We showed that the structure of the H-bond
network of ABT538 bound complex is very different from that of
the cyclic urea inhibitors. For example, besides the H-bonds at the
flap tips and the active site, there are two additional H-bonds at
the lateral sides of flap tips and the active site. In addition, there is
a water molecule W301 which can help the rebinding of H-bonds
at flap tips via its flexible movement. These special properties of
the H-bond network in ABT538 complex make it possible to
achieve the cooperativity of H-bonds in the H-bond network as
well as the coordination between the H-bond network and the
hydrophobic clusters, which ultimately determine the binding
strength between inhibitors and the PR. To the best of our
knowledge, this is the first study of dissecting the dissociation
processes of inhibitor from the HIV-1 PR binding site by more
quantitatively analyzing the stability of the H-bond network.
For further understanding the underlying physics of our
findings, the experimental and numerical evidences supporting
our results will be discussed as following. According to Table 2, we
can see that the dissociation energy barrier DGcal
off obtained by the
umbrella sampling are in a good agreement with the values from
experiments DGEx:
off (see Figure S4 for molecular structure of
Figure 8. Energy landscape of dissociation of the three inhibitors from the binding pocket calculated with the umbrella sampling
simulations. (a) AHA001; (b) XK263 and (c) ABT538. The reaction coordinate was along the pulling direction, of which the origin point
corresponding to the tight structure that the inhibitor was at the right position of active site with intact H-bond networks and hydrophobic
interactions. The color bands in (a), (b) and (c) indicate the positions that the H-bond networks ruptured in the complexes. The snapshots a, b and c
illustrate the conformational transitions of the complexes corresponding to the arrows pointed in (a) to (c). The inhibitors are represented by both
blue and green rods to illustrate the movement tendencies.
doi:10.1371/journal.pone.0019268.g008
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numerical calculations and experiments may come from the
dissociation pathway we chosen. The natural dissociation pathway
may be a somewhat tortuous one rather than the straight one we
chose. Moreover, the dissociation rate constants kcal
off can be
calculated from the dissociation free energy by applying the
Arrhenius equation [52],
koff~
kBT
B

exp {
DGoff
kBT

ð1Þ
where kB is the Boltzmann’s constant, T is the absolute
temperature and B is the Planck’s constant. The calculated
dissociation rate constants kcal
off are in the same order of magnitude
with the values from the experiments kEx:
off . The results showed that
the dissociation rate constant of ABT538 is much lower than those
of the cyclic urea inhibitors AHA001 and XK263.
It was shown that the binding processes of inhibitors to HIV-1
PR exhibit a two-step process [53],
EzI / { { { { ?
k{1
k1
E:I / { { { { ?
k{2
k2
EI ð2Þ
where E represents the PR, I the inhibitor, and the group E?I and
EI represent the loose and tight forms of the bound complexes,
respectively. Note that k1, k{1 and k2, k{2 are the reaction rate
constants of the first and second step, respectively. Previous MD
studies [13,54,55] indicated that the second step, represented by
k2 and k{2, is mainly the conformational transitions and position
adjustments of the protease and inhibitor in order to form a tight
complex. In addition, pervious studies indicated that the
dissociation rate constant koff~k{1k{2= k{1zk2 ðÞ , varying from
3610
25 s
21 to 6610
3 s
21, is mainly dominated by the dissocia-
tion rate constant of the second step k{2 [56].
Our results are consistent with these studies. We showed that the
hydrogen bond network in the AHA001/XK263 bound complexes
ruptured faster than that in the ABT538 bound complex. Once the
H-bond network ruptured, the bound complexes transfer from the
tight form to the loose one, i.e., from EI to E?I as shown in Eq. (2).
This demonstrated that the second step dissociation rate constants
k{2 of the AHA001/XK263 bound complexes were larger than
that of the ABT538 bound complex, therefore resulting in much
faster total dissociation rate of AHA001/XK263 bound complexes
than that of the ABT538 bound complex as shown by the
experimental results [3]. To the best of our knowledge, our results
for the first time explained the underlying mechanisms in atomistic
details why the cyclic urea inhibitors often have fast dissociation
rates shown by experiments [3].
It is noteworthy that the theoretical models developed by Dudko
et al. [25,26] and Hummer & Szabo [57], as well as the models by
Bell [58] and Evans and Ritchie [46] can also be used to calculate
the energy barrier. Compared to these theoretical models, the
umbrella sampling method not only can calculate the energy
barrier, but also can directly calculate the profile of the energy
landscape. For the details of the comparison between these
theoretical models and the umbrella sampling method see Table
S2. In addition, the Jarzynski’s equality method can also be used to
calculate the shape of one-dimensional free energy landscape
[30,59], but it needs a large number of pulling trajectories in order
to reproduce the shape of free energy landscape accurately [60].
To obtain a reliable energy landscape it may require an order of
magnitude longer computing time compared to the umbrella
sampling method [60]. For the details of the comparison between
the Jarzynski’s equality method and the umbrella sampling
method see Figure S5.
To further quantitatively describe the stability of the H-bond
network, we here introduce the concept of the robustness. The
robustness of the H-bond network was defined as the ratio of
strength of the network with one H-bond broken to that of the
intact network, which is given by [61]
rn ðÞ ~1z
kBT ln n ðÞ {Eb
Eb:n
ð3Þ
where kB is the Boltzmann constant, T is the absolute
temperature, Eb is the energy barrier of a single H-bond and n
is the number of H-bonds considered in the system. The 0%
robustness means that the bond network is highly fragile, and the
100% robustness indicates the bond network is highly robust with
maximum fault tolerance. In the cyclic urea inhibitors (AHA001/
XK263) complex, there are about 4 H-bonds in the H-bond
network (see Table 1). As a result, the robustness of the cyclic urea
inhibitor bound complex H-bond network is about 79% (see
Figure 9). In comparison, there are about 6 H-bonds in the H-
bond network of ABT538 bound complex. And the robustness of
the ABT538 bound complex H-bond network is about 87% (see
Figure 9), which is higher than that of cyclic urea inhibitor bound
ones. Thus, the stability of the H-bond network would be less
influenced if one H-bond ruptured in ABT538 bound complex in
comparison with the cyclic urea inhibitor bound complexes. High
robustness will help increase the reforming probability of ruptured
H-bonds. Therefore, the H-bond network in ABT538 bound
complex represents larger fault tolerance capability.
The robustness is crucial for the potent inhibitor design by
considering the frequent mutation of the virus. Because the H-bond
strengthwashighlysensitivetothebondlength(distancebetweenthe
donor and receptor) [62], mutation can significantly influence the
stability of the H-bond network. Previous studies [15] showed that
the mutations of the protease can decrease the effectiveness of the
inhibitors by substantially increasing the dissociation rate constants
(koff). Therefore, the H-bond network with high robustness is highly
desirable for the design of potent inhibitors to resist the effects of
mutation. The high robustness will also allow the coordination
between the H-bond networks and the hydrophobic interactions,
which can further enhance the stability of the H-bond networks.
In summary, we studied the entire dissociation processes of
inhibitors from HIV-1 PR using the SMD simulations and umbrella
sampling simulations with explicit water model. The stability of H-
bond network was analyzed quantitatively to understand the
underlying mechanisms of the significant differences in dissociation
rate constants among different inhibitors. We showed that the
binding strengths of different inhibitors, e.g., AHA001, XK263 and
ABT538, can be distinguished by the rupture forces quantitatively
from the SMD simulations. Detailed analysis of the dissociation
processes of inhibitors from the PR binding pocket showed that the
different binding strength was caused by the difference in the stability
of H-bond networks in the bound complexes. Compared with the
cyclic urea inhibitors complexes, there are more H-bonds at the
lateral sides of the flaps and active sites in the ABT538 bound
complex. In addition, the water molecule W301 enhances the
rebinding of the hydrogen bonds at the flap tips through its flexible
movement. Because of these two superior structural features, the H-
bond network in ABT538 bound complex shows higher robustness
and stability than those of the cyclic urea inhibitor complexes. The
high stability of the H-bond network allows it to have a harmonic
coordination with the hydrophobic cluster so that they can work
together to resist the dissociation. This study presents a microscopic
Strength of Hydrogen Bond Network
PLoS ONE | www.plosone.org 10 April 2011 | Volume 6 | Issue 4 | e19268picture at atomistic details for explaining the large difference in the
dissociation rate constant among different inhibitors, which might
provide important guidelines for design of the novel potent inhibitors
with optimized interactions.
Supporting Information
Figure S1 Dissociation process of XK263 from the
protease. (a) Snapshots of XK263 escaping from the binding
pocket of the protease under the external pulling forces. The
numbers in the panel indicate the lengths of the hydrogen bonds,
and the simulation times were given at the bottom of each
snapshot. (b) The pulling force of XK263 bound complex during
the SMD simulation. The red curve is the average values with a
running average time window of 500 ps. The blue arrows indicate
the critical points of force dropping during the simulation.
(TIF)
Figure S2 Analyses of the dynamics of H-bond interac-
tion and hydrophobic interactions in XK263 bound
complex. (a) to (c) The H-bond lengths between the protease
and the inhibitor XK263 during the pulling simulation. (d)
Evolution of the number of H-bonds between the protease and the
inhibitor XK263 during the simulation. (e) to (h) The distances
between the subsites (S) of protease and the sidechains (P) of
XK263 during the simulation, which were used to monitor the
state of the hydrophobic clusters. The blue arrows indicate the
critical points of bond length change during the simulation.
(TIF)
Figure S3 (a) Pulling force of ABT538 bound complex
with different pulling rates. The pulling distance was defined
by the displacement of the ‘‘dummy’’ atom relative to its original
position during the SMD simulations. The arrows indicate the
time of the hydrogen bonds rupture between the inhibitor
ABT538 and residue Asp29, Gly48. (b) Snapshots of the rupture
of the hydrogen bond formed by ABT538 and residue Asp29.
(TIF)
Figure S4 Molecular structures of two cyclic urea
inhibitors. (a) DMP323 and (b) AHA008.
(TIF)
Figure S5 (a) Free energy landscape of inhibitor ABT538
bound complex obtained by using Jarzynski’s equality and
umbrella sampling methods. The result by Jarzynski’s equality
was obtained from 100 pulling trajectories with kspring =694.8 pN/nm
and pulling velocity 0.5 nm/ns. The parameter n is the number of
different work values chosen at random from the total 100 trajectories,
using the block averaging method. The value of nR‘ is the linear
extrapolation based on the 100 pulling trajectories. (b) The work
distribution in the 100 pulling trajectories at reaction coordination 20 A ˚.
(EPS)
Table S1 Force constants and pulling velocities used in the SMD
simulations.
(DOC)
Table S2 The energy barrier of AHA001 bound complex
predicted by different models/methods.
(DOC)
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Figure 9. Robustness of the H-bond networks in term of the H-bond number. The three curves in the panel show that there are no
significant differences in the robustness value when the single bond energy barriers (effective) change between 5,15 kcal/mol.
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